Clearline Capital’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-79,683
Closed -$790K 146
2024
Q1
$790K Buy
+79,683
New +$790K 0.04% 106